• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过表达 Her2 与 GEP100 的结合诱导自主侵袭活性,并为肺腺癌转移提供生物标志物。

Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.

机构信息

Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

PLoS One. 2011;6(9):e25301. doi: 10.1371/journal.pone.0025301. Epub 2011 Sep 22.

DOI:10.1371/journal.pone.0025301
PMID:21966491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3178645/
Abstract

Overexpression of Her2/ErbB2/Neu in cancer is often correlated with recurrent distant metastasis, although the mechanism still remains largely elusive. We have previously shown that EGFR, when tyrosine-phosphorylated, binds to GEP100/BRAG2 to activate Arf6, which induces cancer invasion and metastasis. We now show that overexpressed Her2 in lung adenocarcinoma cells also employs GEP100. Like EGFR-GEP100 binding, this association is primarily mediated by the pleckstrin homology (PH) domain of GEP100 and Tyr1139/Tyr1196 of Her2. Tyr1139/Tyr1196 are autonomously phosphorylated, when Her2 is overexpressed. Accordingly, invasive activities mediated by the Her2-GEP100 pathway are not dependent on external factors. Blocking Her2-GEP100 binding, as well as its signaling pathway all inhibit cancer invasive activities. Moreover, our clinical study indicates that co-overexpression of Her2 with GEP100 in primary lung adenocarcinomas of patients is correlated with the presence of their node-metastasis with a statistical significance. Since the GEP100 PH domain interacts with both Her2 and EGFR, targeting this domain may provide novel cancer therapeutics.

摘要

在癌症中,Her2/ErbB2/Neu 的过度表达通常与复发性远处转移相关,尽管其机制在很大程度上仍难以捉摸。我们之前已经表明,当 EGFR 酪氨酸磷酸化时,它与 GEP100/BRAG2 结合以激活 Arf6,从而诱导癌症侵袭和转移。我们现在表明,肺腺癌细胞中过表达的 Her2 也利用 GEP100。与 EGFR-GEP100 结合一样,这种关联主要是由 GEP100 的 pleckstrin 同源(PH)结构域和 Her2 的 Tyr1139/Tyr1196 介导的。当 Her2 过表达时,Tyr1139/Tyr1196 会自动磷酸化。因此,Her2-GEP100 途径介导的侵袭活性不依赖于外部因素。阻断 Her2-GEP100 结合及其信号通路均可抑制癌症侵袭活性。此外,我们的临床研究表明,患者原发性肺腺癌中 Her2 与 GEP100 的共过表达与淋巴结转移的存在相关,具有统计学意义。由于 GEP100 PH 结构域与 Her2 和 EGFR 相互作用,针对该结构域可能为癌症治疗提供新的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/de1babb1f999/pone.0025301.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/7031e18e56ef/pone.0025301.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/5e091d15ff86/pone.0025301.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/e21772b173d8/pone.0025301.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/de1babb1f999/pone.0025301.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/7031e18e56ef/pone.0025301.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/5e091d15ff86/pone.0025301.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/e21772b173d8/pone.0025301.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6c/3178645/de1babb1f999/pone.0025301.g004.jpg

相似文献

1
Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.过表达 Her2 与 GEP100 的结合诱导自主侵袭活性,并为肺腺癌转移提供生物标志物。
PLoS One. 2011;6(9):e25301. doi: 10.1371/journal.pone.0025301. Epub 2011 Sep 22.
2
GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.GEP100将表皮生长因子受体信号传导与Arf6激活相联系,以诱导乳腺癌侵袭。
Nat Cell Biol. 2008 Jan;10(1):85-92. doi: 10.1038/ncb1672. Epub 2007 Dec 16.
3
Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.表皮生长因子受体-GEP100-Arf6轴影响肺腺癌的预后。
Oncology. 2014;86(5-6):263-70. doi: 10.1159/000360089. Epub 2014 Jun 4.
4
Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.AMAP1 在细胞侵袭中作为 Arf6 的效应物频繁过表达,这是 MMTV-PyMT 而非 MMTV-Neu 人乳腺癌模型的特征。
Cell Commun Signal. 2018 Jan 5;16(1):1. doi: 10.1186/s12964-017-0212-z.
5
GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.GEP100-Arf6-AMAP1-cortactin 通路在癌症侵袭中经常被激活,该通路由 VEGFR2 激活以促进血管生成。
PLoS One. 2011;6(8):e23359. doi: 10.1371/journal.pone.0023359. Epub 2011 Aug 15.
6
GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.GEP100/Arf6 对于表皮生长因子诱导的 ERK/Rac1 信号通路和人肝癌 HepG2 细胞的迁移是必需的。
PLoS One. 2012;7(6):e38777. doi: 10.1371/journal.pone.0038777. Epub 2012 Jun 11.
7
The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.表皮生长因子受体-GEP100-Arf6-AMAP1信号通路特异性参与乳腺癌侵袭和转移。
Traffic. 2009 Aug;10(8):982-93. doi: 10.1111/j.1600-0854.2009.00917.x. Epub 2009 Apr 21.
8
The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.乳腺癌中的表皮生长因子受体-鸟嘌呤核苷酸交换蛋白100-腺嘌呤核苷释放因子6通路:完全侵袭性并非源于内部。
Cell Adh Migr. 2008 Apr-May;2(2):71-3. doi: 10.4161/cam.2.2.6191. Epub 2008 Apr 23.
9
GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.GEP100 通过激活 Arf6/ERK/uPAR 信号通路调节表皮生长因子诱导的 MDA-MB-231 乳腺癌细胞侵袭。
Exp Cell Res. 2013 Aug 1;319(13):1932-1941. doi: 10.1016/j.yexcr.2013.05.028. Epub 2013 Jun 5.
10
Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.磷脂酰肌醇-4-磷酸 5-激酶和 GEP100/Brag2 蛋白通过 Arf6 蛋白介导信号素 3E-神经丛蛋白 D1 的抗血管生成信号。
J Biol Chem. 2011 Sep 30;286(39):34335-45. doi: 10.1074/jbc.M111.259499. Epub 2011 Jul 27.

引用本文的文献

1
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer.含SH3结构域、锚蛋白重复序列和PH结构域的ArfGAP 1通过磷酸化表皮生长因子受体的负反馈和非小细胞肺癌中核因子-κB的激活反向调节程序性死亡配体1
Cancer Manag Res. 2025 Jan 20;17:91-102. doi: 10.2147/CMAR.S493368. eCollection 2025.
2
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.胰腺癌中的可塑性与肿瘤微环境:遗传学、代谢及免疫视角
Cancers (Basel). 2024 Dec 6;16(23):4094. doi: 10.3390/cancers16234094.
3

本文引用的文献

1
Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer.HER2 信号的过表达激活 WAVE2-Arp2/3 复合物,从而促进乳腺癌中 MMP 非依赖性迁移。
Breast Cancer Res Treat. 2011 Apr;126(2):311-8. doi: 10.1007/s10549-010-0896-x. Epub 2010 Apr 24.
2
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.免疫球蛋白样的Necl-2对ErbB3/ErbB2信号通路的沉默作用
J Biol Chem. 2009 Aug 28;284(35):23793-805. doi: 10.1074/jbc.M109.025155. Epub 2009 Jun 26.
3
Cancer statistics, 2009.
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.
ARF6 介导的肿瘤内在内膜运输塑造了免疫抑制微环境,促进了黑色素瘤的发生发展以及对检查点阻断治疗的反应。
Nat Commun. 2024 Aug 4;15(1):6613. doi: 10.1038/s41467-024-50881-1.
4
Association of ADP‑ribosylation factor family genes with prognosis and immune infiltration of breast cancer.ADP-核糖基化因子家族基因与乳腺癌预后及免疫浸润的关联
Oncol Lett. 2024 Apr 23;27(6):280. doi: 10.3892/ol.2024.14413. eCollection 2024 Jun.
5
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.依赖ARF6的干扰素-γ受体胞吞运输驱动癌症中的适应性免疫抵抗。
bioRxiv. 2023 Oct 2:2023.09.29.560199. doi: 10.1101/2023.09.29.560199.
6
ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity.ADP核糖基化因子6通路是间充质肿瘤可塑性的关键执行者。
Int J Mol Sci. 2023 Oct 5;24(19):14934. doi: 10.3390/ijms241914934.
7
KRAS, MYC, and ARF6: inseparable relationships cooperatively promote cancer malignancy and immune evasion.KRAS、MYC 和 ARF6:不可分割的关系共同促进癌症恶性和免疫逃避。
Cell Commun Signal. 2023 May 8;21(1):106. doi: 10.1186/s12964-023-01130-3.
8
Orchestration of mesenchymal plasticity and immune evasiveness rewiring of the metabolic program in pancreatic ductal adenocarcinoma.胰腺导管腺癌中间充质可塑性的调控与免疫逃逸:代谢程序的重新布线
Front Oncol. 2022 Nov 3;12:1005566. doi: 10.3389/fonc.2022.1005566. eCollection 2022.
9
Activation of the GTPase ARF6 regulates invasion of human vascular smooth muscle cells by stimulating MMP14 activity.ARF6 GTPase 的激活通过刺激 MMP14 活性调节人血管平滑肌细胞的侵袭。
Sci Rep. 2022 Jun 9;12(1):9532. doi: 10.1038/s41598-022-13574-7.
10
Imaging Endocytosis Dynamics in Health and Disease.成像健康与疾病中的内吞作用动力学
Membranes (Basel). 2022 Apr 1;12(4):393. doi: 10.3390/membranes12040393.
2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
4
Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.HER2/neu信号通路介导的miR-21上调促进细胞侵袭。
J Biol Chem. 2009 Jul 3;284(27):18515-24. doi: 10.1074/jbc.M109.006676. Epub 2009 May 6.
5
Overexpression of ErbB2 induces invasion of MCF10A human breast epithelial cells via MMP-9.ErbB2的过表达通过基质金属蛋白酶-9(MMP-9)诱导MCF10A人乳腺上皮细胞的侵袭。
Cancer Lett. 2009 Mar 18;275(2):227-33. doi: 10.1016/j.canlet.2008.10.013. Epub 2008 Nov 20.
6
GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.GEP100将表皮生长因子受体信号传导与Arf6激活相联系,以诱导乳腺癌侵袭。
Nat Cell Biol. 2008 Jan;10(1):85-92. doi: 10.1038/ncb1672. Epub 2007 Dec 16.
7
Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.Heregulin β1可驱动他莫昔芬耐药的MCF-7乳腺癌细胞中吉非替尼耐药的生长和侵袭。
Breast Cancer Res. 2007;9(4):R50. doi: 10.1186/bcr1754.
8
In vivo selection for metastasis promoting genes in the mouse.小鼠体内转移促进基因的选择
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6696-701. doi: 10.1073/pnas.0701145104. Epub 2007 Apr 9.
9
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.HER-2/neu过表达是结直肠癌的一个独立预后因素。
Int J Colorectal Dis. 2007 May;22(5):491-7. doi: 10.1007/s00384-006-0192-8. Epub 2006 Sep 1.
10
HER-2/neu amplification is an independent prognostic factor in gastric cancer.HER-2/neu基因扩增是胃癌的一个独立预后因素。
Dig Dis Sci. 2006 Aug;51(8):1371-9. doi: 10.1007/s10620-005-9057-1. Epub 2006 Jul 26.